Import and supply chain compliance
GDP, Home Office and MHRA frameworks for bringing CBPMs and cannabinoid products into the UK through licensed partners.
Regulatory and quality consultant
CBPM and cannabinoid compliance, from import to inspection
25 years in regulated products. Board level quality and operations at TTS Pharma, Global Head of Quality at Imperial Brands' next generation products unit, and a decade of CQV and QA for GSK, Sanofi, AstraZeneca and Fujifilm Diosynth.
What I help with
Interim, contract and project engagements for cannabis, cannabinoid and novel food businesses that need a regulator ready quality function.
Quality systems, GMP and GDP
Building or rebuilding a QMS that stands up to inspection, from SOPs and training to deviations, CAPA and change control.
Inspection readiness and remediation
Pre inspection gap assessments, mock audits and post inspection CAPA programmes.
Novel foods and CBD compliance
FSA novel food dossiers, labelling, claims and product compliance. Led a dossier covering 860 products across 12 formats.
UK market entry for overseas producers
A UK based quality and compliance lead for cultivators and manufacturers entering the UK market.
Technical due diligence
Quality, compliance and operational review of regulated assets for investors and acquirers.
New to UK imports? Read the guide: Importing CBPMs into the UK
Building a quality system? Read the guide: GMP and GDP quality systems
Track record
0
years in regulated products
0
products in one dossier
0+
team led
0
years at board level
2020 to 2026
TTS Pharma (Group) Ltd
Quality and Operations Director and board member
Vertically integrated cannabinoid and novel foods group. Led the FSA novel food dossier (860 products, 12 formats), built the supply chain and quality system behind it, director of group companies including Endopure Medical.
2017 to 2020
Nerudia and Imperial Brands
Head of Quality and Operations, then Global Head of Quality (blu)
Led a 200+ team through acquisition by Imperial Brands and moved a global FMCG manufacturing base onto pharma grade GMP systems.
2000 to 2017
Pharma CQV and QA
Commissioning, qualification, validation and QA
Commissioning, qualification, validation and QA for GSK, Sanofi, AstraZeneca, Fujifilm Diosynth, Boots and Novartis Vaccines, including FDA and MHRA remediation programmes.
On LinkedIn
Wilson Blaney
Chief Compliance Officer | UK Medical Cannabis & CBD Regulation | MHRA · GDP · Home Office Licensing
Chester, England3,800+ followers
Current
- Chief Compliance Officer, Best Botanicals Ltd
- Managing Director, Medicexum Ltd
- Director Quality Compliance, Sunday Brands
Credentials
- RP (GDP) trained, Inspired Pharma Training, 2026
- QA Lead Auditor trained (IATCA)
- Associate of the Institute of Quality Assurance
- BSc (Hons) Biotechnology
Get in touch
Tell me what you are dealing with and I will come back within one working day.
contact@medicexum.co.uk07919 493939
Engagements are contracted through Medicexum Ltd, registered in England and Wales, with business insurance in place. On site, hybrid or remote, UK and Europe.